Methodologic Approach to Defining Comorbidities in a Cohort of Patients With Cancer: An Example in the Optimal Breast Cancer Chemotherapy Dosing Study

Leveraging both ICD and lab data and extending the lookback period to include postdiagnosis but prechemotherapy initiation may provide better capture of comorbidity. Future studies may consider validating our findings with a gold-standard comorbidity status and in other community health care settings.

Authors

Institutions

Publication Details

Journal
JCO Clinical Cancer Informatics
Published
2025-02-01
DOI
https://doi.org/10.1200/cci-24-00231
Citations
1
Primary Topic
Global Cancer Incidence and Screening
Type
article
Field-Weighted Citation Impact
1.05
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Methodologic Approach to Defining Comorbidities in a Cohort of Patients With Cancer: An Example in the Optimal Breast Cancer Chemotherapy Dosing Study

Elisa V. Bandera, Emily Valice, Jenna Bhimani, Kanichi G. Nakata et al.
1 citations
JCO Clinical Cancer Informatics
Global Cancer Incidence and Screening
1.05
article

Methodologic Approach to Defining Comorbidities in a Cohort of Patients With Cancer: An Example in the Optimal Breast Cancer Chemotherapy Dosing Study

Elisa V. Bandera, Emily Valice, Jenna Bhimani, Kanichi G. Nakata, Rachael P. Burganowski-Doud, Isaac Joshua Ergas, Tatjana Kolevska, Kelli O’Connell, Raymond Liu, Lawrence H. Kushi, Grace Gallagher, Sara Tabatabai, Erin J. Aiello Bowles, Jennifer J. Griggs, Sonia Persaud, Yuriy Kotsurovskyy, Janise M. Roh, Donna R. Rivera, Narre Heon, Candyce H. Kroenke, Elizabeth D. Kantor, Victoria Blinder, Cecile A. Laurent, Peng Wang
article en
1 citations

Abstract

Leveraging both ICD and lab data and extending the lookback period to include postdiagnosis but prechemotherapy initiation may provide better capture of comorbidity. Future studies may consider validating our findings with a gold-standard comorbidity status and in other community health care settings.

JCO Clinical Cancer InformaticsVol. 9(9)
Rutgers, The State University of New Jersey (US), Memorial Sloan Kettering Cancer Center (US), Kaiser Permanente (US), Kaiser Permanente Washington Health Research Institute (US), University of Michigan (US), Kaiser Permanente Vallejo Medical Center (US), Kaiser Permanente San Francisco Medical Center (US), National Cancer Institute (US), Rutgers Cancer Institute (US)
Openalex Percentile: Top 25%
Global Cancer Incidence and Screening
1.05
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.